HURVITZ CHAIM received a stock award from NRX PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 6/10/2021ACC: 0000950142-21-001942
+1.86M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
1.86M acquired
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+1.44M
Price / share
—
Trade value
—
% of position
New position
5/24/2021
0.00→1.44M
Common Stock
Indirect
Shares
+208.44K
Price / share
—
Trade value
—
% of position
New position
5/24/2021
0.00→208.44K
Total
Net shares
+1.64M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/24/2021 | A · Award | +1.44M | — | — | New position | 0.00 | 1.44M |
| Common Stock Indirect | 5/24/2021 | A · Award | +208.44K | — | — | New position | 0.00 | 208.44K |
| Total | +1.64M | $0.00 | ||||||
Derivative Transactions1
Common Stock Warrant (Right to buy)
Indirect
Converts to
Common Stock
218.42K shares
Shares
+218.42K
Strike price
1.53
Held after
218.42K
Exercisable
—
5/24/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Common Stock Warrant (Right to buy) Indirect | Common Stock218.42K shares | 5/24/2021 | A · Award | +218.42K | 1.53 | — | 218.42K |